🇵🇱 INSTYTUT HEMATOLOGII I TRANSFUZJOLOGII PL
Other
INSTYTUT HEMATOLOGII I TRANSFUZJOLOGII is a laboratory accredited by PCA under number AB 1901 (Warszawa, Poland). Its accreditation scope covers 41 test methods in the following areas: Other. Test objects include: Serum, Plasma, Red blood cells, Plasma, Plasma, Serum. Most frequently used techniques: Chemiluminescence method (CMIA), Agglutination method, Real-time PCR method.
At a glance
- Accreditation number: PCA AB 1901
- Methods in scope: 41
- Types of test objects: 6
- Techniques used: 10
- City: Warszawa, Poland
- Accreditation number
- AB 1901
- Accreditation body
- PCA
- Address
- ul. Indiry Gandhi 14, 02-776 Warszawa
- City
- Warszawa, Poland
What this laboratory tests (6)
- Serum, Plasma — 33 methods
- Red blood cells — 3 methods
- Plasma — 2 methods
- Plasma, Serum — 1 method
- Whole blood — 1 method
- Whole blood, Plasma — 1 method
Analytical techniques used (10)
- Chemiluminescence method (CMIA) — 19 methods
- Agglutination method — 7 methods
- Real-time PCR method — 5 methods
- Western blot method — 3 methods
- ELISA method — 2 methods
- Agglutination methods — 1 method
- Chemiluminescence method (CMIA — 1 method
- Haemagglutination method — 1 method
- Real-time RT-PCR method — 1 method
- TMA method — 1 method
Laboratory sections (3)
- DEPARTMENT OF VIROLOGY, CLINICAL VIROLOGY LABORATORY — 26 methods
- DEPARTMENT OF HAEMATOLOGICAL AND TRANSFUSION IMMUNOLOGY, RED BLOOD CELL IMMUNOLOGY LABORATORY — 8 methods
- DEPARTMENT OF VIROLOGY, VERIFICATION TESTING LABORATORY — 7 methods
Laboratory locations
- INSTYTUT HEMATOLOGII I TRANSFUZJOLOGII (main site) — ul. Indiry Gandhi 14, 02-776 Warszawa
- DEPARTMENT OF VIROLOGY — ul. Chocimska 5, 00-791 Warszawa
- VERIFICATION TESTING LABORATORY — ul. Chocimska 5, 00-791 Warszawa
- CLINICAL VIROLOGY LABORATORY — ul. Chocimska 5, 00-791 Warszawa
- DEPARTMENT OF HAEMATOLOGICAL AND TRANSFUSION IMMUNOLOGY — ul. Chocimska 5, 00-791 Warszawa
- RED BLOOD CELL IMMUNOLOGY LABORATORY — ul. Chocimska 5, 00-791 Warszawa
Certificate information
- Issue date
- 27.05.2026
- Issue no.
- 3
Accreditation scope — test methods (41)
| No. | Test object | Methodology / Parameters | Technique | Reference document | |
|---|---|---|---|---|---|
| DEPARTMENT OF VIROLOGY, VERIFICATION TESTING LABORATORY | |||||
| 1 | Serum, Plasma | Presence of anti-HIV antibodies | Western blot method | PB-PBW-21, version 2 of 23.12.2022, based on the manufacturer's instructions, Fujirebio, INNO-LIA HIV I/II Score | |
| 2 | Serum, Plasma | Presence of HIV-1/2 RNA, HCV RNA, HBV DNA | TMA method | PB-PBW-01, version 5 of 24.01.2025, based on the manufacturer's instructions, Grifols Diagnostics, Procleix Ultrio Elite Assay | |
| 3 | Serum, Plasma | Presence of anti-HCV antibodies | Western blot method | PB-PBW-13, version 3 of 16.01.2026, based on the manufacturer's instructions, Fujirebio, INNO-LIA HCV Score | |
| 4 | Serum, Plasma | Presence of anti-Treponema pallidum antibodies | Western blot method | PB-PBW-14, version 3 of 16.01.2026, based on the manufacturer's instructions, Fujirebio INNO-LIA Syphilis Score | |
| 5 | Serum, Plasma | Presence of anti-Treponema pallidum antibodies | Haemagglutination method | PB-PBW-24, version 1 of 02.12.2024 based on the manufacturer's instructions SPINREACT, TPHA | |
| 6 | Serum, Plasma | Presence of HIV-1/2 RNA, HCV RNA, HBV DNA | Real-time PCR method | PB-PBW-22, version 2 of 24.01.2025, based on the Roche manufacturer's instructions, cobas® MPX | |
| 7 | Plasma | Presence and level of B19V DNA | Real-time PCR method | PB-PBW-17, version 2 of 23.12.2022, based on the manufacturer's instructions, BioMerieux, ARGENE Parvovirus B19 R-GENE® | |
| DEPARTMENT OF VIROLOGY, CLINICAL VIROLOGY LABORATORY | |||||
| 8 | Serum, Plasma | Presence of HBs antigen | Chemiluminescence method (CMIA) | PB-PWK-44 version 4 from 03.01.2025, based on the manufacturer's instructions for the Abbott diagnostic test and the Alinity i analyser | |
| 9 | Serum, Plasma | Confirmation of the presence of HBs antigen | Chemiluminescence method (CMIA) | PB-PWK-44 version 4 from 03.01.2025, based on the manufacturer's instructions for the Abbott diagnostic test and the Alinity i analyser | |
| 10 | Serum, Plasma | Presence of HBc antibodies | Chemiluminescence method (CMIA) | PB-PWK-44 version 4 from 03.01.2025, based on the manufacturer's instructions for the Abbott diagnostic test and the Alinity i analyser | |
| 11 | Serum, Plasma | Presence of IgM HBc antibodies | Chemiluminescence method (CMIA) | PB-PWK-44 version 4 from 03.01.2025, based on the manufacturer's instructions for the Abbott diagnostic test and the Alinity i analyser | |
| 12 | Serum, Plasma | Presence and level of HBs antibodies | Chemiluminescence method (CMIA) | PB-PWK-44 version 4 from 03.01.2025, based on the manufacturer's instructions for the Abbott diagnostic test and the Alinity i analyser | |
| 13 | Serum, Plasma | Presence of HBe antibodies | Chemiluminescence method (CMIA) | PB-PWK-44 version 4 from 03.01.2025, based on the instructions for the Abbott diagnostic test and the Alinity i analyser | |
| 14 | Serum, Plasma | Presence of HBe antigen | Chemiluminescence method (CMIA) | PB-PWK version 4 from 03.01.2025, based on the Abbott diagnostic test manufacturer's instructions and the Alinity i instrument | |
| 15 | Serum, Plasma | Presence of HCV antibodies | Chemiluminescence method (CMIA) | PB-PWK-44 version 4 from 03.01.2025, based on the manufacturer's instructions for the Abbott diagnostic test and the Alinity i analyser | |
| 16 | Serum, Plasma | Presence of HIV1/2 antibodies and antigen | Chemiluminescence method (CMIA) | PB-PWK-44 version 4 from 03.01.2025, based on the manufacturer's instructions for the Abbott diagnostic test and the Alinity i analyser | |
| 17 | Serum, Plasma | Presence of T. pallidum antibodies | Chemiluminescence method (CMIA) | PB-PWK-44 version 4 from 03.01.2025, based on the manufacturer's instructions for the Abbott diagnostic test and the Alinity i analyser | |
| 18 | Serum, Plasma | Presence of HTLV I/II antibodies | Chemiluminescence method (CMIA) | PB-PWK-44 version 4 from 03.01.2025, based on the manufacturer's instructions for the Abbott diagnostic test and the Alinity i analyser | |
| 19 | Serum, Plasma | Presence and level of CMV IgG antibodies | Chemiluminescence method (CMIA | PB-PWK-44 version 4 from 03.01.2025, based on the manufacturer's instructions for the Abbott diagnostic test and the Alinity i analyser | |
| 20 | Serum, Plasma | Presence of IgM CMV antibodies | Chemiluminescence method (CMIA) | PB-PWK-44 version 4 from 03.01.2025, based on the manufacturer's instructions for the Abbott diagnostic test and the Alinity i analyser | |
| 21 | Serum, Plasma | Presence and level of Toxo IgG antibody | Chemiluminescence method (CMIA) | PB-PWK-44 version 4 from 03.01.2025, based on the manufacturer's instructions for the Abbott diagnostic test and the Alinity i analyser | |
| 22 | Serum, Plasma | Presence of IgM Toxo antibodies | Chemiluminescence method (CMIA) | PB-PWK-44 version 4 from 03.01.2025, based on the manufacturer's instructions for the Abbott diagnostic test and the Alinity i analyser | |
| 23 | Serum, Plasma | Presence of IgG VCA EBV antibodies | Chemiluminescence method (CMIA) | PB-PWK-44 version 4 from 03.01.2025, based on the manufacturer's instructions for the Abbott diagnostic test and the Alinity i analyser | |
| 24 | Serum, Plasma | Presence of IgM VCA EBV antibodies | Chemiluminescence method (CMIA) | PB-PWK-44 version 4 from 03.01.2025, based on the manufacturer's instructions for the Abbott diagnostic test and the Alinity i analyser | |
| 25 | Serum, Plasma | Presence of IgG EBNA EBV antibodies | Chemiluminescence method (CMIA) | PB-PWK-44 version 4 from 03.01.2025, based on the manufacturer's instructions for the Abbott diagnostic test and the Alinity i analyser | |
| 26 | Serum, Plasma | Presence of IgG HAV antibodies | Chemiluminescence method (CMIA) | PB-PWK-44 version 4 from 03.01.2025, based on the manufacturer's instructions for the Abbott diagnostic test and the Alinity i analyser | |
| 27 | Serum, Plasma | Presence of IgM HAV antibodies | Chemiluminescence method (CMIA) | PB-PWK-44 version 4 from 03.01.2025, based on the manufacturer's instructions for the Abbott diagnostic test and the Alinity i analyser | |
| 28 | Serum, Plasma | Presence and level of B19V IgG antibodies | ELISA method | PB-PWK-26 version 8 from 27.01.2026, based on the manufacturer's instructions for the Institut Virion/Serion diagnostic test | |
| 29 | Serum, Plasma | Presence and level of B19V IgM antibodies | ELISA method | PB-PWK-26 version 8 from 27.01.2026, based on the manufacturer's instructions for the Institut Virion/Serion diagnostic test | |
| 30 | Whole blood | Presence and level of CMV DNA | Real-time PCR method | PB-PWK-25 version 10 from 03.01.2025 based on the manufacturer's instructions BioMerieux, ARGENE CMV R-GENE® | |
| 31 | Whole blood, Plasma | Presence and level of EBV DNA | Real-time PCR method | PB-PWK-37 version 5 from 03.01.2025 based on the manufacturer's instructions BioMerieux, ARGENE EBV R-GENE® | |
| 32 | Plasma | Presence and level of B19V DNA | Real-time PCR method | PB-PWK-43 version 5 from 29.01.2025, based on the BioMerieux manufacturer's instructions, ARGENE Parvovirus B19 R-GENE® | |
| 33 | Plasma, Serum | Presence and level of HEV RNA | Real-time RT-PCR method | PB-PWK-40 version 8 from 03.01.2025, based on the manufacturer's instructions, Altona Diagnostics RealStar HEV RT-PCR kit 2.0 | |
| DEPARTMENT OF HAEMATOLOGICAL AND TRANSFUSION IMMUNOLOGY, RED BLOOD CELL IMMUNOLOGY LABORATORY | |||||
| 34 | Red blood cells | Determination of antigens on red blood cells ABO system: A, B Rh system: D, C, c, E, e, Cw Kell system: K, k Kidd system: Jka, Jkb System: Fya, Fyb MNS system: M, N, S, s |
Agglutination method | PB-PKCz-07 version 5 of 08.01.2025 | |
| 35 | Red blood cells | Determination of antigens on red blood cells ABO system: A, B Rh system: D, C, c, E, e Kell system: K, k Kidd system: Jka, Jkb MNS system: M, N, S, s |
Agglutination method | PB-PKCz-09 version 1 of 05.01.2026 | |
| 36 | Red blood cells | Presence of IgG, IgM, IgA antibodies, and complement components C3c, C3d on red blood cells | Agglutination method | PB-PKCz-07 version 5 of 08.01.2025 | |
| 37 | Serum, Plasma | Presence and identification of immune alloantibodies to red blood cell antigens | Agglutination method | PB-PKCz-07 version 5 of 08.01.2025 | |
| 38 | Serum, Plasma | Presence and identification of immune alloantibodies to red blood cell antigens | Agglutination method | PB-PKCz-09 version 1 of 05.01.2026 | |
| 39 | Serum, Plasma | Presence of autoantibodies | Agglutination method | PB-PKCz-07 version 5 of 08.01.2025 | |
| 40 | Serum, Plasma | Presence of autoantibodies | Agglutination method | PB-PKCz-09 version 1 of 05.01.2026 | |
| 41 | Serum, Plasma | Determination of IgG and/or IgM antibody titre | Agglutination methods | PB-PKCz-07 version 5 of 08.01.2025 | |
Reference standards (19)
PB-PBW-01, version 5 of 24.01.2025, based on the manufacturer's instructions, Grifols Diagnostics, Procleix Ultrio Elite Assay
PB-PBW-13, version 3 of 16.01.2026, based on the manufacturer's instructions, Fujirebio, INNO-LIA HCV Score
PB-PBW-14, version 3 of 16.01.2026, based on the manufacturer's instructions, Fujirebio INNO-LIA Syphilis Score
PB-PBW-17, version 2 of 23.12.2022, based on the manufacturer's instructions, BioMerieux, ARGENE Parvovirus B19 R-GENE®
PB-PBW-21, version 2 of 23.12.2022, based on the manufacturer's instructions, Fujirebio, INNO-LIA HIV I/II Score
PB-PBW-22, version 2 of 24.01.2025, based on the Roche manufacturer's instructions, cobas® MPX
PB-PBW-24, version 1 of 02.12.2024 based on the manufacturer's instructions SPINREACT, TPHA
PB-PKCz-07 version 5 of 08.01.2025
PB-PKCz-07 version 5 of 08.01.2025
PB-PKCz-09 version 1 of 05.01.2026
PB-PKCz-09 version 1 of 05.01.2026
PB-PWK-25 version 10 from 03.01.2025 based on the manufacturer's instructions BioMerieux, ARGENE CMV R-GENE®
PB-PWK-26 version 8 from 27.01.2026, based on the manufacturer's instructions for the Institut Virion/Serion diagnostic test
PB-PWK-37 version 5 from 03.01.2025 based on the manufacturer's instructions BioMerieux, ARGENE EBV R-GENE®
PB-PWK-40 version 8 from 03.01.2025, based on the manufacturer's instructions, Altona Diagnostics RealStar HEV RT-PCR kit 2.0
PB-PWK-43 version 5 from 29.01.2025, based on the BioMerieux manufacturer's instructions, ARGENE Parvovirus B19 R-GENE®
PB-PWK-44 version 4 from 03.01.2025, based on the manufacturer's instructions for the Abbott diagnostic test and the Alinity i analyser
PB-PWK-44 version 4 from 03.01.2025, based on the instructions for the Abbott diagnostic test and the Alinity i analyser
PB-PWK version 4 from 03.01.2025, based on the Abbott diagnostic test manufacturer's instructions and the Alinity i instrument